ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Calidi Biotherapeutics Inc

Calidi Biotherapeutics Inc (CLDI)

0.7582
0.1326
(21.20%)
Closed February 01 4:00PM
0.78
0.0218
(2.88%)
After Hours: 7:59PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.78
Bid
-
Ask
-
Volume
7,230,045
0.60 Day's Range 0.8395
0.58 52 Week Range 16.80
Market Cap
Previous Close
0.6256
Open
0.62
Last Trade
1848
@
0.7582
Last Trade Time
Financial Volume
$ 5,318,890
VWAP
0.735665
Average Volume (3m)
1,801,981
Shares Outstanding
13,078,022
Dividend Yield
-
PE Ratio
-0.34
Earnings Per Share (EPS)
-2.23
Revenue
-
Net Profit
-29.22M

About Calidi Biotherapeutics Inc

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the FLAGLSX-Forensic Accounting Long-Short Index. The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the FLAGLSX-Forensic Accounting Long-Short Index.

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Wilmington, Delaware, USA
Founded
-
Calidi Biotherapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the American Stock Exchange with ticker CLDI. The last closing price for Calidi Biotherapeutics was $0.63. Over the last year, Calidi Biotherapeutics shares have traded in a share price range of $ 0.58 to $ 16.80.

Calidi Biotherapeutics currently has 13,078,022 shares outstanding. The market capitalization of Calidi Biotherapeutics is $8.18 million. Calidi Biotherapeutics has a price to earnings ratio (PE ratio) of -0.34.

CLDI Latest News

Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on February 5

SAN DIEGO, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted...

Calidi Biotherapeutics Announces Bolstered Cash Balance and Termination of its Standby Equity Purchase Agreement

SAN DIEGO, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted...

Calidi Biotherapeutics Announces Presentation of New Data of Systemic Virotherapy RTNova Platform at the AACR Annual Meeting in April 2025

SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted...

Calidi Biotherapeutics Announces Closing of $4.25 Million Public Offering of Common Stock

SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted...

Calidi Biotherapeutics Announces Pricing of $4.25 Million Public Offering of Common Stock

SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company developing a new generation of...

Calidi Biotherapeutics Announces Proposed Public Offering

SAN DIEGO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company developing a new generation of...

Calidi Biotherapeutics Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer

SAN DIEGO, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted...

Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock

SAN DIEGO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted...

Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock

SAN DIEGO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company developing a new generation of...

Calidi Biotherapeutics Announces Proposed Public Offering

SAN DIEGO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company developing a new generation of...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.02483.283898305080.75520.80.586517590.65511514CS
4-0.45-36.58536585371.231.490.5811295260.99755277CS
12-0.78-501.563.890.5818019812.09686982CS
26-0.89-53.29341317371.673.890.5810246821.89250487CS
52-7.73-90.83431257348.5116.80.5811419262.494439CS
156-44.32-98.270509977845.1500.588427582.92426656CS
260-44.32-98.270509977845.1500.588427582.92426656CS

CLDI - Frequently Asked Questions (FAQ)

What is the current Calidi Biotherapeutics share price?
The current share price of Calidi Biotherapeutics is $ 0.78
How many Calidi Biotherapeutics shares are in issue?
Calidi Biotherapeutics has 13,078,022 shares in issue
What is the market cap of Calidi Biotherapeutics?
The market capitalisation of Calidi Biotherapeutics is USD 8.18M
What is the 1 year trading range for Calidi Biotherapeutics share price?
Calidi Biotherapeutics has traded in the range of $ 0.58 to $ 16.80 during the past year
What is the PE ratio of Calidi Biotherapeutics?
The price to earnings ratio of Calidi Biotherapeutics is -0.34
What is the reporting currency for Calidi Biotherapeutics?
Calidi Biotherapeutics reports financial results in USD
What is the latest annual profit for Calidi Biotherapeutics?
The latest annual profit of Calidi Biotherapeutics is USD -29.22M
What is the registered address of Calidi Biotherapeutics?
The registered address for Calidi Biotherapeutics is CORPORATION TRUST CENTER, 1209 ORANGE ST, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Calidi Biotherapeutics website address?
The website address for Calidi Biotherapeutics is www.calidibio.com
Which industry sector does Calidi Biotherapeutics operate in?
Calidi Biotherapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DXFEason Technology Limited
$ 26.00
(57.29%)
895.37k
SGNSigning Day Sports Inc
$ 3.73
(45.70%)
56.03M
CLDICalidi Biotherapeutics Inc
$ 0.7629
(21.95%)
7.23M
XTNTXtant Medical Holdings Inc
$ 0.6149
(15.50%)
99.67k
NNVCNanoViricides Inc
$ 1.185
(10.75%)
684.82k
EXODExodus Movement Inc
$ 50.00
(-18.54%)
155.49k
SENSSenseonics Holdings Inc
$ 0.9609
(-11.84%)
17.03M
CPHIChina Pharma Holdings Inc
$ 0.2183
(-9.91%)
325.86k
GOROGold Resource Corporation
$ 0.3462
(-9.56%)
1.49M
EONREON Resources Inc
$ 0.82
(-9.50%)
1.63M
SOXLDirexion Daily Semiconductor Bull 3X Shares
$ 27.02
(-0.48%)
102.26M
SPXSDirexion Daily S&P 500 Bear 3X Shares New
$ 5.82
(1.39%)
81.08M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
$ 2.3017
(-2.26%)
75.06M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF
$ 3.565
(7.70%)
70.47M
SOXSDirexion Daily Semiconductor Bear 3X Shares New
$ 20.61
(0.73%)
67.19M

CLDI Discussion

View Posts
Eagle1 Eagle1 1 day ago
Let's ride this to $1.00++ soon. CLDI .78 cents now. Chart Looks primed here with CLDI Calidi Biotherapeutics Ends SEPA After Successful Fundraising

Story Highlights
Calidi Biotherapeutics terminated its SEPA with Yorkville effective January 23, 2025.
The company raised $9.6 million by December 31, 2024, enhancing its cash position and focus on clinical goals.
👍️0
glenn1919 glenn1919 1 day ago
CLDI........................................................https://stockcharts.com/h-sc/ui?s=CLDI&p=W&b=5&g=0&id=p86431144783
👍️0
Eagle1 Eagle1 1 day ago
Hi Glen in here with you at .73 cents


CLDI.........................https://stockcharts.com/h-sc/ui?s=CLDI&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 1 month ago
CLDI, under $2
👍️0
glenn1919 glenn1919 2 months ago
CLDI.........................https://stockcharts.com/h-sc/ui?s=CLDI&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 3 months ago
CLDI......................https://stockcharts.com/h-sc/ui?s=CLDI&p=W&b=5&g=0&id=p86431144783
👍️0
tw0122 tw0122 3 months ago
$3.50 + 70% Pump time next resistance at $3.80 if it got crazy next level in $5s 
👍️0
glenn1919 glenn1919 3 months ago
CLDI....................................https://stockcharts.com/h-sc/ui?s=CLDI&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 3 months ago
CLDI.........................................https://stockcharts.com/h-sc/ui?s=CLDI&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 3 months ago
CLDI.............................https://stockcharts.com/h-sc/ui?s=CLDI&p=W&b=5&g=0&id=p86431144783
👍️0
tw0122 tw0122 3 months ago
Go again lol $1.17 back to .99
Or ready to pump 
👍️0
totffe totffe 3 months ago
Yep, golden opportunity!
👍️0
totffe totffe 3 months ago
LOL, well no one is selling and the stock showed good gains end of week. Very bullish!
👍️0
ErnieBilco ErnieBilco 3 months ago
They were not BUYS but option awards not one of them have exercised their right to buy at $1.09.

It is not bullish at all
👍️0
Monksdream Monksdream 3 months ago
CLDI under $2
👍️0
totffe totffe 4 months ago
Fantastic buying opportunity. 6 company officers filed Form 4's last week, all buys. Bullish
👍️0
Monksdream Monksdream 4 months ago
CLDI new 52 week low
👍️ 1 😎 1
Monksdream Monksdream 5 months ago
CLDI under $2
👍️0
Monksdream Monksdream 5 months ago
CLDI new 52=week low
👍️0
TrendTrade2016 TrendTrade2016 6 months ago
CLDI..NEXT POST SPLIT BUCKAROO!!!!
👍️0
Monksdream Monksdream 6 months ago
CLDI under $2
👍️0
Monksdream Monksdream 6 months ago
CLDI under $2
👍️0
ErnieBilco ErnieBilco 7 months ago
Probably because it is a worthless company that is heavily in debt and by all rights it should be kicked off the Nasdaq but Nasdaq urges these worthless companies to screw their shareholders to artificially get their stock price to $1 - I expect a landslide decline back to a quarter in short order.

This is one of my bets that doesn't look like it will make me any money - unless they can somehow pump it up on the fact the the OS will be about 5 million shares on split day.

Just my take on it after looking thru Q1 Quarterly report.
👍️0
JTORENCE JTORENCE 7 months ago
Ernie Bilco You may have predicted right. Reverse splits are usually the death blow for a stock. Hope not. Why did they do this??
👍️0
Invest-in-America Invest-in-America 8 months ago
CLDI: News --- collaboration with SIGA to kill all Cancers.
👍️0
Termite7 Termite7 8 months ago
Keeping an eye...... coiled!!!
👍️0
accipiterr accipiterr 9 months ago
April 24th webinar
https://redchip.zoom.us/webinar/register/WN_qT-PBRbTQ0yLeBbJ4jzPSw
in this one they mention 3 different times that they are talking to large pharmaceutical companies about licencing and about how the recent data, specifically for RTnova, has resulted in high level discussions with more planned in the near future.


May 9th webinar
https://sidoti.zoom.us/webinar/register/WN_p8GBAbbqTd2OuYnM33eTuQ#/registration
👍️0
accipiterr accipiterr 9 months ago
Bottom in, looks ready for a move up. Data being presented on June 1st.
👍️0
ErnieBilco ErnieBilco 9 months ago
Yikes, RedChip is usually the kiss of death for all the stocks they have pumped or paid promoted
👍️0
Legend431 Legend431 10 months ago
Looking good
👍️0
Triple nickle Triple nickle 10 months ago
Here we gooooo
👍️0
2020trader 2020trader 10 months ago
DOWN 6% TODAY....EXPECTING LOWER
👍️0
glenn1919 glenn1919 11 months ago
CLDI................................................https://stockcharts.com/h-sc/ui?s=CLDI&p=W&b=5&g=0&id=p86431144783
👍️0

Your Recent History

Delayed Upgrade Clock